NLRP3 and hepatocellular carcinoma: Studies have shown that SRI regulates VEGFA/B expression via the PI3K pathway and negatively modulates pyroptosis by interacting with the NLRP3 inflammasome, thereby promoting hepatocellular carcinoma proliferation.19